Answers are grounded in this paper and cite their sources.
Type 2 diabetes mellitus (T2DM) is a global health challenge; therefore, safe and effective dietary interventions are required. We investigated the hypoglycemic effects of fermented Laminaria japonica in streptozotocin-induced diabetic mice, and elucidated the underlying mechanisms through integrated transcriptomic and gut microbiota analyses. Diabetic mice were orally administered fermented L. japonica, non-fermented L. japonica, or metformin for 4 weeks. Fermented L. japonica treatment significantly ameliorated hyperglycemia, improved insulin sensitivity, increased hepatic glycogen storage, and restored antioxidant enzyme (catalase, glutathione peroxidase, and total superoxide dismutase) activities compared to the NFS treatment. Transcriptomic analysis revealed that fermented L. japonica modulated key metabolic pathways, including PI3K-Akt signaling and AMPK activation, with upregulated gene expression associated with glucose metabolism (Prkag3 and Tmem100) and oxidative stress response (Ddit4 and Apod). Additionally, 16S rRNA sequencing demonstrated that fermented L. japonica reshaped the gut microbiota by enriching beneficial short-chain fatty acid-producing taxa (Limosilactobacillus and unclassified Lachnospiraceae) and suppressing potentially harmful genera. Overall, fermentation enhanced the anti-diabetic efficacy of L. japonica through the multi-target regulation of insulin signaling, oxidative stress, and gut microbiota composition, establishing fermented L. japonica as a promising functional food candidate for the adjunctive management of T2DM.
No takes yet. Share an insight, caveat, or question.
Yue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: